Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience

Leuk Lymphoma. 2016 Oct;57(10):2429-31. doi: 10.3109/10428194.2015.1137293. Epub 2016 Jan 27.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Aged
  • Anemia, Hemolytic, Autoimmune / chemically induced*
  • Anemia, Hemolytic, Autoimmune / epidemiology*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bendamustine Hydrochloride / administration & dosage
  • Bendamustine Hydrochloride / adverse effects*
  • Female
  • Humans
  • Incidence
  • Italy / epidemiology
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / epidemiology
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Retrospective Studies
  • Rituximab / administration & dosage
  • Rituximab / adverse effects*

Substances

  • Rituximab
  • Bendamustine Hydrochloride